Amylin (AMLN) is looking to sell itself, according to sources, and has hired advisers to help...
Amylin (AMLN) is looking to sell itself, according to sources, and has hired advisers to help solicit possible offers. Several companies, possibly including Sanofi (SNY), are reportedly considering a bid to gain access to Amylin's diabetes portfolio.
From other sites
Bristol Myers Squibb : OPINION: From the Editor: Fill Your Bucket List Foundation grants wishes to adult cancer patientsat 4-traders.com (Mar 24, 2015)
at Benzinga.com (Feb 26, 2015)
at Benzinga.com (Feb 25, 2015)
at CNBC.com (Feb 17, 2015)
at Investor's Business Daily (Jan 27, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs